Epilepsy Does Not Appear to Affect Likelihood of Pregnancy

Share this content:
Epilepsy Does Not Appear to Affect Likelihood of Pregnancy
Epilepsy Does Not Appear to Affect Likelihood of Pregnancy

WEDNESDAY, May 2, 2018 (HealthDay News) -- Women with epilepsy and no history of infertility have a similar likelihood of achieving pregnancy as peers without epilepsy, according to a study published online April 30 in JAMA Neurology.

Page B. Pennell, M.D., from Brigham and Women's Hospital in Boston, and colleagues used data from 89 women with epilepsy and 108 controls without epilepsy in the Women With Epilepsy: Pregnancy Outcomes and Deliveries study. The women were seeking pregnancy between ages 18 and 40 years and were enrolled in the study within six months of discontinuing contraception. The researchers assessed whether the likelihood of achieving pregnancy is biologically reduced in women with epilepsy compared with their peers.

The researchers found that 60.7 percent of the women with epilepsy and 60.2 percent of the control women achieved pregnancy within 12 months after enrollment. There was no difference in median time to pregnancy between the groups (six versus nine months; P = 0.3) after the researchers controlled for key covariates. Furthermore, sexual activity and ovulatory rates were similar between the groups, and the percentage of live births was 81.5 percent in both groups.

"Women with epilepsy seeking pregnancy without prior known infertility or related disorders have similar likelihood of achieving pregnancy, time to pregnancy, and live birth rates compared with their peers without epilepsy," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »